Found 197 clinical trials
Avatrombopag in the Treatment of Adult Immune Thrombocytopenia With Autoantibodies
This prospective, open-label, single-center, one-arm clinical trial aims at evaluating the efficacy and safety of avatrombopag in Chinese adult Immune Thrombocytopenia (ITP) patients with
- 0 views
- 12 Aug, 2021
- 1 location
Study of Human Umbilical Cord-derived Mesenchymal Stem Cells for Treatment of Refractory Immune Thrombocytopenia
Primary Objective: To evaluate the safety and efficacy of human umbilical cord-derived mesenchymal stem cellshUC-MSCs to treat refractory immune thrombocytopeniaITP. Secondary Objective: To observe the changes of immune function in refractory ITP patients with human umbilical cord-derived mesenchymal stem cellshUC-MSCs after infusion, and to explore and reveal the mechanism of …
- 0 views
- 11 Jul, 2021
- 1 location
Using Romiplostim to Treat Low Platelet Counts During Chemotherapy in People With Lymphoma
The purpose of this study is to see if the study drug, romiplostim, helps low platelet count caused by standard chemotherapy treatment for lymphoma. This study will also look at whether romiplostim can prevent the need for chemotherapy dose delays, chemotherapy dose reductions, and platelet transfusions. In addition, we will …
- 0 views
- 16 Aug, 2021
- 8 locations
Nomacopan (rVA576) in Transplant Associated Thrombotic Microangiopathy
Multicentre Study of nomacopan in Paediatric Haematopoietic Stem-Cell Transplant Associated Thrombotic Microangiopathy
- 0 views
- 14 Mar, 2021
- 1 location
The Effect of REcombinant Human Thrombopoietin (rhTPO) on Sepsis Patients With aCUte Severe thrombocytopEnia
platelet transfusion and bleeding events, prompt recovery of organ function, decrease the length of ICU stay, and eventually reduce the 28-day mortality in sepsis patients with severe thrombocytopenia.
- 0 views
- 05 Mar, 2021
- 1 location
The Efficacy and Safety of Huaiqihuang Granule in Children With Chronic Primary Immune Thrombocytopenia
chronic primary immune thrombocytopenia (Qi Yin deficiency).
- 0 views
- 02 Aug, 2021
- 14 locations
The Safety Tolerability Pharmacokinetics and Preliminary Efficacy of HMPL-523 in Immune Thrombocytopenia Patients
This is a randomized, double blinded, placebo-controlled phase Ib clinical trial in adult patients with immune thrombocytopenia. Cross-over treatment will be allowed during the study.
- 7 views
- 26 Jan, 2021
- 1 location
Eltrombopag vs Standard Front Line Management for Newly Diagnosed Immune Thrombocytopenia (ITP) in Children
This is an investigator initiated, multicenter, open label, randomized phase 3 study for subjects with newly diagnosed ITP from ages 1 to less than 18 years old.
- 10 views
- 06 Oct, 2021
- 11 locations
The Combination of Tacrolimus and High-dose Dexamethasone as First-line Treatment in Adult Immune Thrombocytopenia
of adults with primary immune thrombocytopenia (ITP).
- 0 views
- 18 Feb, 2021
- 1 location
Eltrombopag Combined With Low-dose Rituximab in the Treatment of Adult Immune Thrombocytopenia With Autoantibodies
therapyBATin adult immune thrombocytopenia with autoantibodies fail (due to intolerance or resistance) to first-line treatment.
- 0 views
- 14 Jun, 2021
- 1 location